These data are broadly consistent with previous reports of ILC populations in human gut.12, 13, 14 Crucially, IL6 increased pathogenic cytokine production by CD3- IL7R+ cLPMCs from IBD patients in a dose-dependent manner, consistent with our preclinical data showing IL6-responsive colonic ILC3s. This evidence concerns the gene IL6 and inflammatory bowel disease.